- Home
- SNY vs CRWD Comparison
SNY vs CRWD Comparison
Compare SNY & CRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNY
- CRWD
- Stock Information
- Founded
- SNY 1994
- CRWD 2011
- Country
- SNY France
- CRWD United States
- Employees
- SNY N/A
- CRWD N/A
- Industry
- SNY Biotechnology: Pharmaceutical Preparations
- CRWD EDP Services
- Sector
- SNY Health Care
- CRWD Technology
- Exchange
- SNY Nasdaq
- CRWD Nasdaq
- Market Cap
- SNY 113.4B
- CRWD 103.5B
- IPO Year
- SNY N/A
- CRWD 2019
- Fundamental
- Price
- SNY $46.97
- CRWD $445.50
- Analyst Decision
- SNY Buy
- CRWD Buy
- Analyst Count
- SNY 4
- CRWD 44
- Target Price
- SNY $61.50
- CRWD $464.00
- AVG Volume (30 Days)
- SNY 2.7M
- CRWD 3.4M
- Earning Date
- SNY 10-24-2025
- CRWD 08-27-2025
- Dividend Yield
- SNY 3.40%
- CRWD N/A
- EPS Growth
- SNY 118.56
- CRWD N/A
- EPS
- SNY 8.65
- CRWD N/A
- Revenue
- SNY $53,714,621,258.00
- CRWD $4,341,102,000.00
- Revenue This Year
- SNY $1.53
- CRWD $23.41
- Revenue Next Year
- SNY $7.06
- CRWD $21.85
- P/E Ratio
- SNY $5.43
- CRWD N/A
- Revenue Growth
- SNY 15.65
- CRWD 23.46
- 52 Week Low
- SNY $44.73
- CRWD $263.45
- 52 Week High
- SNY $60.12
- CRWD $517.98
- Technical
- Relative Strength Index (RSI)
- SNY 43.02
- CRWD 58.37
- Support Level
- SNY $46.50
- CRWD $402.66
- Resistance Level
- SNY $47.69
- CRWD $448.87
- Average True Range (ATR)
- SNY 0.68
- CRWD 14.56
- MACD
- SNY -0.18
- CRWD 4.54
- Stochastic Oscillator
- SNY 36.14
- CRWD 83.44
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
About CRWD CrowdStrike Holdings Inc.
CrowdStrike is a cloud-based cybersecurity company specializing in next-generation security verticals such as endpoint, cloud workload, identity, and security operations. CrowdStrike's primary offering is its Falcon platform that offers a proverbial single pane of glass for an enterprise to detect and respond to security threats attacking its IT infrastructure. The Texas-based firm was founded in 2011 and went public in 2019.